2013;347:f5934
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
Upon binding to GLP-1, GLP-1R activates intracellular signaling pathways, such as cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA), which mediate its physiological effects
Participants using semaglutide have reported more significant weight loss compared to those on a placebo, with effects that are sustainable over the long term
Hi There, Download the PharmEasy App now
Species and strains While some probiotic supplements cram as many bacterial species as possible in a capsule (e.g., Seeds Daily Synbiotic has two dozen), Pendulum has elected to build its product line around just five species selected to deliver a relatively narrow set of health improvements: General gut health and metabolism Appetite regulation Type 2 diabetes management Below, we discuss the science behind each strain